---
title: "Onconetix (ONCO.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ONCO.US/norm.md"
symbol: "ONCO.US"
name: "Onconetix"
parent: "https://longbridge.com/zh-HK/quote/ONCO.US.md"
datetime: "2026-05-19T19:35:35.583Z"
locales:
  - [en](https://longbridge.com/en/quote/ONCO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ONCO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ONCO.US/norm.md)
---

# Onconetix (ONCO.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -6.71 | 18.07 | -31.25 | -34.55 | -197.26 |
| ROE | -122.56% | 236.99% | -756.90% | -312.73% | -545.39% |
| 營業收入 | 21457.00 | 303596.00 | 303651.00 | 106494.00 | 101630.00 |
| 凈利潤 | -4.21M | 5.67M | -8.78M | -3.87M | -8.55M |
| 營業利潤 | -2.09M | -1.28M | -2.07M | -1.34M | -1.65M |
| 毛利率 | -7.71% | 81.58% | 88.55% | 66.20% | 45.10% |
| 凈利率 | -19643.36% | 1867.51% | -2892.70% | -2227.77% | -8408.82% |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 14.83M | 24.93M | 19.68M | 19.12M | 18.78M |
| 權益乘數 | 1.26 | 1.58 | 5.83 | 3.24 | 4.70 |
| 每股凈資產 | 4.26 | 50.53 | 10.81 | 29.29 | 46.16 |
| 資產周轉率 | 0.0438 | 0.0307 | 0.0300 | 0.0338 | 0.0410 |
| 現金及短投 | 3.72M | 5.22M | 836556.00 | 283515.00 | 1.58M |
| 存貨與應收 | 137642.00 | 149961.00 | 151556.00 | 153072.00 | 155660.00 |
| 長期投資 | 74259.00 | 85859.00 | 46543.00 | 65209.00 | 145613.00 |
| 凈債務 | -3.43M | -5.17M | -670134.00 | 8.47M | 7.47M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -2.12M | -3.09M | -3.18M | -1.41M | -2.00M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 631788.00 | 6.55M | 4.29M | 744574.00 | 2.87M |
| 自由現金流 | -7.39M | -8.20M | 11.10M | -1.66M | -5.39M |
| 現金流充裕率 | - | -1882.35% | -58.74% | -235.14% | -213.29% |
| 舉債與償債 | 247196.00 | 460875.00 | 400000.00 | 375000.00 | 100000.00 |
| 資本支出 | - | - | - | - | - |